Identification of Corticotropin-Releasing Factor (CRF) Target Cells and Effects of Dexamethasone on Binding in Anterior Pituitary Using a Fluorescent Analog of CRF*

Jeffrey Schwartz, Nils Billestrup, Marilyn H. Perrin, J. Cipolla Marilyn, Wylie Vale

Endocrinology · 1986 · 45 citations · 14 references

Concepts

Abstract

A fluorescein-conjugated bioactive analog of corticotropin-releasing factor (CRF) was synthesized and used to label cells that have high affinity CRF-binding sites. Of cultured bovine anterior pituitary cells, 6.1 +/- 0.6% were visible by fluorescence microscopy after incubation with the analog. Fluorescence was eliminated by coincubation with a 200-fold excess of unlabeled CRF. Treatment with dexamethasone (10(-9)-10(-7) M) decreased visible fluorescence in a dose-dependent manner. These results demonstrate the utility of a fluorescent CRF analog for identification of cells with specific CRF-binding sites and suggest that binding of CRF to anterior pituitary cells is altered by glucocorticoids.

References

14